MSTN and muscular dystrophy: Since the initial discovery of myostatin as a potent inhibitor of muscle growth [147,148], intense effort has been invested to block myostatin actions to treat muscle-wasting diseases, with therapeutic promise in ameliorating muscular dystrophies through pharmacological inhibition [149].